In our meta-analysis, we could not obtain information from all studies on the blood pressure, weight status, insulin or diabetes conditions which were main risk factors for dyslipidemia, and lacking of those original data limited our further evaluation of potential interactions. This evidence concerns the gene INS and metabolic syndrome.